Page last updated: 2024-09-05

lapatinib and Cardiomyopathy, Hypertrophic

lapatinib has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bedja, D; Belmonte, F; Gabrielson, K; Guo, X; Kang, B; Pin, S; Sysa-Shah, P; Tsuchiya, N; Xu, Y	1

Other Studies

1 other study(ies) available for lapatinib and Cardiomyopathy, Hypertrophic

Article	Year
Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice. PloS one, 2012, Volume: 7, Issue:8 Topics: Animals; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Cell Survival; Electrophysiological Phenomena; Gene Expression; Isoproterenol; Lapatinib; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Organ Size; Organ Specificity; Protein Biosynthesis; Quinazolines; Rats; Receptor, ErbB-2; Signal Transduction	2012

Article

Year

Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice.

PloS one, 2012, Volume: 7, Issue:8

Topics: Animals; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Cell Survival; Electrophysiological Phenomena; Gene Expression; Isoproterenol; Lapatinib; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Organ Size; Organ Specificity; Protein Biosynthesis; Quinazolines; Rats; Receptor, ErbB-2; Signal Transduction

2012